Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Vernakalant Hydrochloride: Precision Workflows in Rapid AF C
2026-07-02
Vernakalant Hydrochloride (RSD1235) empowers researchers with rapid, atrial-selective conversion of atrial fibrillation, delivering quantifiable efficacy and reproducibility in both in vitro and in vivo settings. This guide details actionable protocols, advanced applications, and troubleshooting strategies using APExBIO’s rigorously validated compound.
-
Propranolol: Applied Workflows for Essential Tremor and Beyo
2026-07-02
Propranolol, a non-selective β-adrenergic receptor blocker, is central to research on essential tremor, cardiovascular regulation, and emotional memory modulation. This article delivers actionable protocols, advanced troubleshooting, and insight into the latest neurophysiological findings—translating deep mechanistic understanding into reliable experimental results.
-
Superoxide Dismutase (SOD) Activity Assay Kit: Technical Gui
2026-07-01
The Superoxide Dismutase (SOD) Activity Assay Kit (SKU: K2035) enables researchers to quantitatively assess SOD enzyme activity in biological fluids, supporting studies of oxidative stress and antioxidative defense. This kit is intended for research use only and is not suitable for diagnostic or clinical applications.
-
Trolox in Organoid and Disease Modeling: Advanced Antioxidan
2026-07-01
Explore how Trolox, a water-soluble vitamin E analogue, enables robust oxidative injury and organoid modeling beyond standard antioxidant assays. This article reveals new research and practical guidance for leveraging Trolox as a precision tool in cutting-edge biomedical studies.
-
Merbromin Selectively Inhibits SARS-CoV-2 3CLpro: Mechanisti
2026-06-30
The referenced study identifies merbromin as a mixed-type and selective inhibitor of the SARS-CoV-2 main protease 3CLpro, sparing major proteases such as Proteinase K. This finding advances the mechanistic understanding of protease inhibitor selectivity and provides a basis for targeted antiviral drug design.
-
Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer
2026-06-30
This study dissected the contributions of mitochondrial-linked apoptosis and necroptosis to skeletal muscle atrophy during ovarian cancer progression in a mouse model. While mitochondrial ROS-driven caspase activation was attenuated by SkQ1, muscle atrophy persisted, indicating that neither mitochondrial apoptosis nor necroptosis are primary drivers of type II B muscle fiber loss in this setting.
-
Griseofulvin as a Precision Probe for Mitotic Error Pathways
2026-06-29
Explore how Griseofulvin, a microtubule associated inhibitor, enables advanced research into mitotic error pathways and fungal cell mitosis inhibition. This article reveals novel assay strategies and scientific insights not covered elsewhere.
-
Flumequine (SKU B2292): Reliable DNA Topoisomerase II Inhibi
2026-06-29
This article equips biomedical researchers with scenario-driven solutions for DNA replication and cytotoxicity assays using Flumequine (SKU B2292). By grounding protocols in peer-reviewed evidence and product-specific data, we demonstrate how Flumequine enhances assay reproducibility, sensitivity, and reliability for DNA topoisomerase II inhibition studies.
-
EdU Flow Cytometry Assay Kits (Cy3): Streamlining S-Phase An
2026-06-28
The EdU Flow Cytometry Assay Kits (Cy3) from APExBIO transform cell proliferation and genotoxicity workflows with high-sensitivity S-phase detection and robust, multiplex-ready performance. By eliminating harsh DNA denaturation and leveraging click chemistry, these kits empower researchers to achieve reproducible, high-throughput results—even in challenging models such as environmental carcinogen-exposed tumors.
-
Pregnenolone Carbonitrile: Precision Tools for CYP3A Inducti
2026-06-27
Pregnenolone Carbonitrile (PCN) stands as the benchmark PXR agonist for dissecting hepatic detoxification and antifibrotic mechanisms in rodent models. This guide unpacks experimental workflows, protocol optimizations, and troubleshooting strategies to maximize data quality in xenobiotic metabolism and neuroprotection studies.
-
GRA12: A Conserved Toxoplasma Virulence Factor Revealed by I
2026-06-26
The reference study employs systematic in vivo CRISPR-Cas9 screens to identify GRA12 as a critical secreted virulence factor shared across Toxoplasma gondii strains and mouse subspecies. These findings highlight GRA12’s central role in parasite survival and immune evasion, offering new avenues for host-pathogen interaction research.
-
Dabigatran Etexilate: Mechanistic Depth and Assay Innovation
2026-06-26
Explore the advanced mechanism and unique in vitro and in vivo assay applications of Dabigatran etexilate, a leading direct thrombin inhibitor. This article delivers a deeper mechanistic analysis and practical insights for optimizing anticoagulant research.
-
Leupeptin, Microbial (Leupeptin hemisulfate): Reliable Prote
2026-06-25
This article addresses real-world laboratory challenges in protease activity regulation and protein degradation workflows, showing how Leupeptin, Microbial (Leupeptin hemisulfate) (SKU A2570) enhances reproducibility and data quality. Scenario-driven Q&A blocks illustrate practical choices and protocol optimization, with evidence-backed recommendations for biomedical researchers.
-
Zolmitriptan: 5-HT1B Receptor Agonist Workflows for Migraine
2026-06-25
Zolmitriptan enables high-fidelity modeling of serotonin-driven migraine and cluster headache mechanisms, with robust solubility and stability for advanced in vitro and in vivo assays. This article distills experimental best practices, troubleshooting tips, and lessons from cross-domain lysosomal research to enhance your serotonin receptor pharmacology workflows.
-
MLKL Polymerization Induces Lysosomal Permeabilization in Ne
2026-06-24
This study reveals that MLKL polymerization triggers lysosomal membrane permeabilization (LMP), preceding plasma membrane rupture and leading to the release of cathepsins—especially Cathepsin B—which drives necroptotic cell death. The findings clarify a critical mechanistic step in necroptosis execution, with implications for targeting lysosomal proteases in cell death and disease.